-
Are there specific legal requirements or preferences regarding the choice of entity and/or equity structure for early-stage businesses that are seeking venture capital funding in the jurisdiction?
The choice of legal structure when establishing an early-stage business is a fundamental decision that not only defines the legal and organizational framework for future operations but also has an impact on tax and accounting obligations, the formalities required for the formation process, and the way investors or financial institutions evaluate the target. In Germany, there are no mandatory legal requirements regarding the choice of legal form for early-stage companies seeking venture capital. However, in market practice, the establishment of the limited liability company (Gesellschaft mit beschränkter Haftung) with a required share capital of EUR 25,000.00 has prevailed.
This preference primarily results from the limited liability protection provided to the shareholders. In a limited liability company, the liability of each shareholder is restricted to the amount of its capital contribution, meaning that private assets remain unaffected if the company faces financial difficulties. In addition, the structure of a limited liability company allows for flexibility in investor participation, as the share capital is divided into transferable shares with a nominal value of EUR 1.00 each. The limited liability company is therefore particularly well suited for early-stage financing rounds and subsequent investments, offering both a clear ownership structure and legal certainty for investors.
In contrast, partnerships (Personengesellschaften) – although relatively fast and inexpensive to establish – are less common in the German venture capital ecosystem. This is primarily due to the unlimited personal liability of the founding members, which poses significant risks to the founders. Additionally, the participation by investors structured as tax-transparent investment funds can adversely affect their own tax status when investing in partnerships, making this legal form unattractive in a venture capital context.
For founders with a long-term objective of pursuing an initial public offering, there also exists the option of setting up a German stock corporation (Aktiengesellschaft). However, in Germany a stock corporation involves increased organizational and legal efforts and requires a minimum share capital of EUR 50,000.00. Therefore, the formation of German stock corporations is the exception rather than the rule. If the desire to go public arises after the founding process, a limited liability company can be converted into a stock corporation by way of a change of legal form (Formwechsel) without creating tax disadvantages.
-
What are the principal legal documents for a venture capital equity investment in the jurisdiction and are any of them publicly filed or otherwise available to the public?
In the context of a venture capital financing, the core transaction documents consist of the investment agreement, the shareholders’ agreement and the articles of association. Typically, the transaction process is preceded by the negotiation of a term sheet, which outlines the key commercial and legal terms of the investment on a non-binding basis and serves as the framework for drafting the definitive agreements.
The investment and shareholders’ agreements constitute the contractual foundation for the investor’s financial participation in the company and for the ongoing cooperation between the parties. They usually consist of two independent parts, the investment agreement, which sets out the terms and conditions of the investor’s financial participation in the start-up, and the shareholders’ agreement, which governs the future relationship and rights between the founding shareholder(s) and investor(s) as (future) shareholders of the company. In practice, these two parts are either combined into one agreement or concluded as two separate agreements. If the target is a German limited liability company pursuant to the German Limited Liability Companies Act (GmbHG), usually, the signing of the investment documentation requires notarization by a public notary, particularly due to provisions concerning the transfer or issuance of shares. This notarization requirement can entail significant transaction costs, depending on the size of the investment.
With respect to the company’s articles of association, the independent regulatory content of the articles of association is limited as the material commercial and legal agreements between the founding shareholder(s) and venture capital investors are contained in the investment and shareholders’ agreement. Therefore, only those provisions having mandatory corporate law character are typically included in the company’s articles of association. Nevertheless, the articles of association are a mandatory part of every venture capital investment documentation as it is necessary to align the articles of association with the investment and shareholders’ agreement. Furthermore, several ancillary documents such as managing director service agreements, rules of procedure for the management and/or an advisory board and agreements on (virtual) employee incentive schemes are regularly negotiated in the course of a venture capital funding.
Regarding publication requirements, neither the investment agreement nor the shareholders’ agreement (nor the other accompanying documents) must be filed with or published in the company’s commercial register. Therefore, the respective provisions contained in investment and shareholders’ agreements remain confidential and cannot be reviewed by third parties. In contrast, the articles of association are available for public inspection in the company’s commercial register, as well as a list of the shareholders and their respective shareholdings in the company.
-
Is there a venture capital industry body in the jurisdiction and, if so, does it provide template investment documents? If so, how common is it to deviate from such templates and does this evolve as companies move from seed to larger rounds?
There is no specific venture capital industry body in Germany comparable, for example, to the National Venture Capital Association in the US. However, there are certain private initiatives such as sector associations providing publicly available template documentation for the foundation and (seed) funding rounds. While such templates are sometimes used in the seed funding rounds, the investment documentation during the subsequent funding rounds is still predominantly drawn up individually by the lawyers based on their standards due to the increasing complexity of the investment structure. Unlike in the US or the UK, where templates issued and annotated by the National Venture Capital Association and the British Venture Capital Association, respectively, are widely used, the German venture capital market lacks authoritative standard-form documents. While deal terms have converged fairly significantly as the market has matured, this absence of universally accepted templates continues to trigger discussions around governance, vesting terms, representations and warranties and other items in early-stage equity rounds, thereby increasing transaction costs and prolonging negotiations. In recent years, there have been various initiatives by stakeholders in the venture capital and legal communities to reach a more formal consensus on deal terms and to provide standard-form documents. These efforts are ongoing and, coupled with advances in document automation and legal technology, can be expected to enhance efficiency in venture capital deal-making in the future.
-
Are there any general merger control, anti-trust/competition and/or foreign direct investment regimes applicable to venture capital investments in the jurisdiction?
Venture capital investments are in this regard subject to the same legal framework as other (M&A / financing) transactions in Germany. However, seed and early-stage venture capital transactions are in general due to their size not subject to anti-trust/competition law and merger control. However, transactions involving state-backed venture capital investors, corporate venture vehicles of large industrial companies, or business angels with multiple investments may become subject to merger control if the relevant turnover thresholds under the German Act against Restraints of Competition (Gesetz gegen Wettbewerbsbeschränkungen (GWB)) are exceeded. In such cases, the transaction must be notified to the German Federal Cartel Office (Bundeskartellamt) for review.
In addition, foreign direct investment (FDI) screening has become a key additional workstream for venture capital deals in Germany. Unlike merger control, the German FDI screening regime under the Foreign Trade and Payments Act (Außenwirtschaftsgesetz (AWG)) and the Foreign Trade and Payments Ordinance (Außenwirtschaftsverordnung, (AWV)) is not subject to turnover or deal-value thresholds. Depending on the target’s sector of activity, a mandatory notification obligation may be triggered already at an acquisition of 10% of the voting rights (in certain sensitive sectors, e.g. defence, critical infrastructure and dual-use goods) or 25% of the voting rights (in the cross-sectoral review). Notifiable transactions are subject to a statutory standstill obligation (Vollzugsverbot): completion is prohibited until the Federal Ministry of Economic Affairs and Energy (Bundesministerium für Wirtschaft und Energie) has either granted approval or allowed the applicable review period to lapse. Closing in breach of the standstill constitutes a regulatory offence (Ordnungswidrigkeit) or, in certain cases, a criminal offence (Straftat) and may render the transaction legally void (schwebend unwirksam).
This is of particular relevance in the rapidly growing German defence-tech sector – as illustrated by high-profile venture-backed companies such as Helsing (AI-powered defence software), Quantum Systems (autonomous aerial systems), Tytan (defence drones) and STARK (hypersonic technology). In these sensitive sectors, the 10% threshold applies with particular rigour and – notably – may extend to investors from EU and EFTA member states. Moreover, follow-on financing rounds independently trigger a fresh notification obligation each time an additional voting rights threshold is crossed, making FDI analysis a recurrent and indispensable element of deal planning throughout the entire investment lifecycle.
Keeping a close eye on merger control and (in particular) defence related FDI screening is therefore essential to avoid closing delays, unenforceability/standstill breaches and potentially significant fines.
-
What is the process, and internal approvals needed, for a company issuing shares to investors in the jurisdiction and are there any related taxes or notary (or other fees) payable?
A share capital increase in a limited liability company first requires the adoption of a valid shareholders’ resolution, specifying the concrete terms of the capital increase – in particular the exact amount by which the share capital shall be increased. This resolution also provides for a corresponding amendment to the articles of association due to the change in share capital. Such resolution must be notarized and adopted by a qualified majority of at least 75% of the votes cast, unless the company’s articles of association provide for stricter requirements.
The existing shareholders of the company are granted a statutory subscription right (Bezugsrecht) in the event of the capital increase in order to have the opportunity to maintain their proportional ownership before and after the increase. Following the adoption of the shareholders’ resolution, the company and the respective subscriber will sign a certified subscription form (Übernahmeerklärung). Subsequently, the subscriber is obliged to pay the issue price (i.e. the nominal amount of (in general) EUR 1.00 per share) for the respective newly issued shares. After the payment of the nominal amount(s) for the subscribed shares the company’s managing directors(s) will apply for the registration of the capital increase with the company’s commercial register. With the respective approval and registration of the capital increase in the company’s commercial register, the capital increase becomes legally effective and further additional investment obligations (associated with the subscribed shares) will become due and payable.
In practice, this process also involves the notarization of the capital increase resolution, as well as the notarization of the investment and shareholders’ agreement, which may trigger significant notary fees depending on the transaction value. However, specific taxes (such as stamp duties) do not apply when subscribing to newly issued shares within a venture capital transaction.
-
How prevalent is participation from investors that are not venture capital funds, including angel investors, family offices, high net worth individuals, and corporate venture capital?
Angel investors have consistently played a significant role in the German venture capital ecosystem. Business angels are typically experienced entrepreneurs who invest at very early stages and contribute not only capital but also operational know-how and access to their networks. Compared to venture capital funds, angel investments are characterised by earlier entry, closer involvement in the development phase, lower entry valuations and, correspondingly, higher risk. The German angel investor landscape is broad and highly active, with several thousand active private investors organised in networks and clubs across the country. Currently, business angels account for more than 25% of venture capital investments, underlining their importance as a key source of early-stage financing and as a bridge between seed funding and institutional venture capital.
In terms of family offices, they have historically been slower to adopt venture capital as an alternative asset class, primarily due to their traditionally risk-averse investment strategies. In Germany, family offices have therefore predominantly invested in venture capital funds as limited partners rather than making direct investments. Recently, however, the number of family offices engaging in direct venture capital investments has increased. Many now pursue a hybrid approach, allocating their venture capital exposure between managed funds and selective direct investments.
The participation of corporate venture capitalists in the venture capital ecosystem has increased significantly in recent years, in line with global developments. In Germany, corporate venture capital (CVC) has emerged as a key driver of innovation and growth and plays a particularly strong role by international comparison. Germany is one of the leading CVC markets in Europe, hosting the largest number (approximately 130) of corporate venture programmes on the continent, and ranks among the most relevant CVC markets globally. CVC represents a substantial share of venture capital investments in Germany and is driven by a clear win-win rationale: corporate investors enhance their competitiveness and gain access to new technologies and business fields, while founders benefit from a stable strategic partner that may also act as a potential exit partner at a later stage. Sector-wise, CVC activity in Germany is closely aligned with the country’s industrial and economic structure, with a focus on engineering, financial services, AI, aerospace and green/clean technologies, alongside increasing diversification into sectors such as media, food and retail.
It remains to be seen whether CVCs, family offices, and other non-traditional investors will continue to expand their participation in venture capital in 2026 in a world of increasing political uncertainty.
-
What is the typical investment period for a venture capital fund in the jurisdiction?
Venture capital funds typically have a limited lifespan of 7 to 12 years, with evergreen structures remaining a rare exception in the German market. As most portfolio companies require at least 4 to 5 years – often longer – to achieve the scale necessary to attract a strategic buyer or generate a meaningful return, venture capital funds generally focus on building their core portfolio within the first 3 to 4 years following the fund’s inception. Accordingly, the active investment period of a venture capital fund usually spans 3 to 6 years.
However, since early 2022 the venture exit environment in Germany and Europe (in particular IPOs and trade sales) has been materially more constrained, while a persistent mismatch between seller price expectations and buyer valuation levels has often delayed realizations. This has translated into longer average holding periods and an increased reliance on interim liquidity measures – such as bridge rounds and other short-term financing instruments (including convertible loans/notes) – with value realization frequently occurring later than originally assumed in fund underwriting. Against this backdrop, managers have increasingly turned to secondary-led liquidity solutions, including LP-led sales and GP-led continuation vehicles (often combined with tender offers/partial rollovers), to provide liquidity to existing investors and/or to extend ownership of select assets rather than crystallizing returns at depressed valuations; under current market conditions, these structures are likely to remain a relevant feature of exit planning in Germany through 2026.
-
What are the key investment terms which a venture investor looks for in the jurisdiction including representations and warranties, class of share, board representation (and observers), voting and other control rights, redemption rights, anti-dilution protection and information rights?
As part of the investment agreement, the terms most relevant to a venture capital investor typically include (i) the company’s current valuation including the basis of its calculation (usually on a fully diluted basis), (ii) the specific investment amount and the class of preferred shares to be subscribed by the investor, (iii) an independent title and business guarantee catalogue, (iv) provisions governing liability caps and other limitations of liability in the event of breaches of such guarantees, (v) the applicable limitation periods; and (vi) anti-dilution protection rights, which may range from broad-based weighted average to full ratchet mechanisms.
Under the shareholders’ agreement, individual investors or groups of investors – often acting through a supervisory or advisory body whose members are primarily appointed by the venture capital investors – typically secure consent rights and protective provisions with respect to certain fundamental corporate actions. These usually cover structural measures, such as additional capital increases or the creation of new share classes, as well as specific management decisions, reflecting the fact that venture capital investors generally hold only a minority stake in the company. Such consent rights are generally not intended to interfere with the company’s ordinary course of business but are limited to actions that may have a material financial or structural impact on the company.
Furthermore, a venture capital investor will secure its investment through specific rights, including: (i) information and reporting rights, (ii) exit-related rights (e.g. lock-up provisions, tag- and drag-along rights) and (iii) disposal restrictions. The core commercial element of the shareholders’ agreement is the liquidation and proceeds preference based on which (exit) proceeds will be distributed among the shareholders. The prevailing standard in Germany is the “last in, first out” principle, implemented through a non-participating liquidation preference (einfache anrechenbare Erlösverteilungspräferenz). This mechanism ensures that the investor receives a return of its original investment amount before any distributions are made to ordinary shareholders and is primarily designed to provide downside protection in the event of an exit.
-
What are the key features of the liability regime (e.g. monetary damages vs. compensatory capital increase) that apply to venture capital investments in the jurisdiction?
The liability regime governing venture capital investments in Germany is primarily contractually defined through investment and shareholders’ agreements, which set out detailed remedies available to investors in case of breaches by founders or selling shareholders.
Usually, restitution in kind (Naturalrestitution) serves as the principal remedy for breaches of representations and warranties, whether title or business guarantees. Where restitution in kind proves impossible or is not effectuated within a prescribed timeframe (typically one month), the breaching party must provide monetary damages for actual losses sustained, calculated in accordance with sections 249 et seq. of the German Civil Code (Bürgerliches Gesetzbuch).
In addition to monetary compensation, investment and shareholders’ agreements frequently incorporate compensatory capital increase mechanisms as an alternative remedy. This means that, in certain cases (typically for breaches of business guarantees), the investor may opt to receive additional shares in the company to reflect the diminished value of the company caused by the breach. The number of shares to be issued is usually calculated based on a reduced pre-money valuation of the company that reflects the financial impact of the breach. To facilitate this, all shareholders are generally obliged to support the corresponding capital increase and waive any pre-emptive or other conflicting rights.
To limit liability, the parties frequently include caps and thresholds. Common limitations include capping liability at the amount invested by the investor or at the founder’s annual gross salary. Additionally, compensation is only granted if both of the following conditions are met: (i) each individual claim exceeds a specified minimum threshold (de minimis amount), and (ii) the aggregate sum of all such claims surpasses an agreed threshold (basket amount). These thresholds are structured in a way that, once exceeded, the entire amount can be claimed.
Moreover, statutory warranty rights and legal provisions that would otherwise provide for broader remedies (e.g., under the German Commercial Code (Handelsgesetzbuch) or the German Civil Code (Bürgerliches Gesetzbuch)) are often contractually excluded, unless the breach was caused by intent, gross negligence, or fraud. In such cases, exclusions and limitations of liability do not apply. To prevent overlapping or multiple recoveries, the agreements usually contain provisions ensuring that the same damage cannot be claimed more than once, even if multiple guarantees are affected.
Finally, limitation periods are contractually agreed upon and typically range from 24 months to 5 years after signing, depending on the type of guarantee and the subject matter (e.g. extended periods for tax-related breaches). These limitation periods may be suspended by timely written notices but are subject to defined maximum periods to ensure legal certainty.
-
How common are arrangement/ monitoring fees for investors in the jurisdiction?
Apart from limited director’s fees for serving on the advisory board of a target company, arrangement or monitoring fees for investors are uncommon in Germany.
-
Are founders and senior management typically subject to restrictive covenants following ceasing to be an employee and/or shareholder and, if so, what is their general scope and duration?
As standard practice in German venture capital investments, founders and – where deemed necessary by the investor(s) – certain key employees are subject to post-contractual non-compete and non-solicitation obligations. These restrictions are designed to prevent the exploitation of company-specific know-how in a manner detrimental to the company’s business interests, whether directly or indirectly.
Such covenants typically remain effective for up to 2 years following the individual’s departure from the company as a shareholder and/or employee. The scope of these restrictions is, however, limited in terms of subject matter and geography, usually confined to the business areas and regions in which the company operated at the time of the individual’s exit. In the event of a breach of these restrictive covenants, the departing individual is ordinarily subject to a contractual penalty and/or may be required to transfer portions of its shares in the company to the remaining shareholders or the company itself. Passive minority investments in competing businesses – particularly where the investor holds no controlling influence – are often excluded from the non-compete obligations, depending on the specific agreement between the parties.
-
How are employees typically incentivised in venture capital backed companies (e.g. share options or other equity-based incentives)?
Employee incentives in Germany are commonly structured through either virtual shares (i.e. contractual payment claims instead of real shares) or real equity participation. Virtual shares have traditionally predominated because they avoid immediate taxation upon grant (“dry income”) and do not confer shareholder status, significantly simplifying administration, particularly when employees leave the company.
However, the German Future Financing Act (Zukunftsfinanzierungsgesetz (ZuFinG)) which entered into force on December 18, 2023, and the Annual Tax Act 2024 (Jahressteuergesetz 2024) have significantly improved the tax treatment of real stock options in accordance with Section 19a of the Income Tax Act (Einkommenssteuergesetz (EStG)). Due to these reforms, taxation is deferred until the exit (instead of when they are granted) and profits are taxed at approx. 25% as capital income (Einkünfte aus Kapitalvermögen) instead of up to 45% as earned income (Einkünfte aus nichtselbständiger Arbeit), making real capital participation significantly more tax-efficient for employees. The eligibility criteria were expanded to cover a broader range of companies: companies must have fewer than 250 employees, less than EUR 50 million in turnover and assets of less than EUR 43 million at the time of the grant or in any of the six calendar years prior to the grant, and the company must be less than 20 years old at the time of the grant. At the same time, the entitlement to capital participation in the parent company has been extended and the annual allowance (jährlicher Freibetrag) has been increased to EUR 2,000. Despite these improvements, uncertainties and costs around determining applicable valuations at grant and structuring complexities – particularly where companies wish to roll out equity schemes to a larger number of employees while keeping their cap table manageable, often necessitating pooling arrangements or management companies as intermediaries – continue to limit the practical impact of the reforms. Some market participants have therefore pushed for hybrid instruments such as profit participation rights (Genussrechte), seeking to combine the tax advantages of real shares provided by the new rules with the ease and cost-efficient administration applicable to virtual instruments. As a result, the current German start-up landscape displays a mixed pattern of tools and approaches to employee incentive schemes, and it remains to be seen whether virtual shares will in future still predominate the employee incentivisation within the German venture capital environment.
-
What are the most commonly used vesting/good and bad leaver provisions that apply to founders/ senior management in venture capital backed companies?
Standard vesting provisions require founders or employees to transfer their shares (whether directly or indirectly held) to the company or other shareholders upon specific “leaver” events, typically governed by purchase and assignment agreements.
The number and the equivalent value of the shares to be transferred is regularly determined based on the time and/or reason for the resignation and/or termination of the respective concerned individual (so called “bad leaver” or “good leaver” events) whereby the most commonly used vesting period amounts to forty-eight months with a linear monthly vesting and a one year cliff.
Bad leaver events typically include (i) termination for good cause (aus wichtigem Grund) attributable to the individual, (ii) resignation without good cause (ohne wichtigen Grund) and (iii) material breach of statutory or contractual duties or non-compete obligations. Good leaver events typically include (i) termination or removal by the company without good cause (ohne wichtigen Grund), (ii) resignation by the individual for good cause (mit wichtigem Grund) attributable to the company or (iii) death or permanent incapacity.
The legal consequences following the respective leaver event are usually a core point of negotiations within a venture capital transaction. In case of a bad leaver event the concerned individual is typically obliged to transfer all of its shares for a consideration of the respective shares’ nominal value. In case of a good leaver event, the unvested part of the shares is usually transferred for a consideration of the respective shares’ nominal value and the vested part of the shares remains with the concerned individual.
Good and bad leaver provisions are also common in virtual share option plans. However, following the Federal Labour Court’s (Bundesarbeitsgericht) decision of March 19, 2025, such provisions must be carefully drafted. The court held that forfeiture clauses causing vested virtual options to lapse upon voluntary resignation constitute inappropriate discrimination against employees and are therefore invalid. Consequently, vested virtual options must generally remain exercisable even after voluntary termination, subject to the programme’s other terms.
-
What have been the main areas of negotiation between investors, founders, and the company in the investment documentation, over the last 24 months?
Over the last 24 months, valuation resets and a higher incidence of flat and down rounds have pushed negotiations away from “headline valuation” and deeper into the economic plumbing of the deal. As a result, the most heavily negotiated areas have typically been downside protection – most notably the structure of liquidation preferences and anti-dilution protection (with broad-based weighted average remaining the default in approximately 80% of rounds with anti-dilution protection, while more aggressive tools such as full-ratchet mechanisms tend to appear mainly in distressed or highly investor-led financings and remain limited to around 2% of transactions globally). Alongside economics, negotiations have also intensified around governance and control (board composition and consent/veto matters), with a notable increase in the allocation of board observer seats to investors’ representatives, reflecting investors’ growing appetite for engagement in their portfolio companies’ governance and business aspects. Furthermore, investor protections in follow-on rounds (pro rata and pre-emption mechanics), milestone-based tranching of investment commitments, and, increasingly, secondary liquidity and transfer restrictions have been key areas of negotiation. In addition, cumulative dividend rights – guaranteeing returns such as compounding interest as part of the liquidation preference irrespective of the company’s financial performance – have gained traction globally, though they remain less prevalent in the German market.
-
How prevalent is the use of convertible debt (e.g. convertible loan notes) and advance subscription agreement/ SAFEs in the jurisdiction?
In Germany, convertible loan agreements remain the prevailing financing instrument to raise capital in a fast and cost-efficient manner without having to (immediately) implement a notarised capital increase. However, also SAFEs (Simple Agreements for Future Equity) are on the rise and are now becoming more popular in the German venture capital environment.
However, SAFEs cannot be used without adjustment due to the regulations applicable in Germany on the implementation of capital increases. In addition, some legal uncertainties remain – especially depending on the specific structuring and the relevant form requirements – given the limited amount of clear-cut case law (Rechtsprechung). In particular, under German GAAP and commercial law, SAFEs may not clearly qualify as debt or equity, creating classification problems for both founders and investors. Some German tax authorities consider SAFEs a form of debt instrument, while others treat them more akin to advance payments or options, and the lack of binding legal precedent has led to diverging practices in documentation, accounting and tax filings. As a result, structured hybrid SAFEs have emerged in the German market that incorporate certain investor protections common to convertible loans, such as valuation caps, pro rata rights, board observers and veto rights on key matters. Against this background, it can be expected that convertible loan agreements will continue to be predominant for short-term venture capital financings in Germany.
-
What are the customary terms of convertible debt (e.g. convertible loan notes) and advance subscription agreement/ SAFEs in the jurisdiction and are there standard from documents?
Convertible loan agreements and SAFEs generally follow a similar principle: the investor provides capital to the company in exchange for the right to subscribe to shares in the future. However, convertible loan agreements and SAFEs differ in several aspects:
On one hand, a convertible loan agreement is a standard loan combined with a contractually agreed right for conversion of the loan amount. Convertible loan agreements typically have a fixed term – typically ranging from 1 to 3 years (with 2 years being common market practice) – during which the loan accrues interest. The interest rates usually agreed range from 0% to 10%. Interest is generally rolled up and added to the conversion amount rather than paid in cash; if no conversion occurs, interest becomes repayable with the principal at maturity, subject to any subordination arrangements. Furthermore, qualified subordination (qualifizierter Rangrücktritt) is a standard feature, particularly to avoid balance-sheet issues in insolvency tests and to meet regulatory requirements. Conversion is typically triggered by (i) the next equity financing round (often defined by a minimum size threshold), (ii) liquidity events such as an exit or change of control, or (iii) maturity. In each case, a unilateral right of the investor or the company or a bilateral right or a general obligation to convert is subject to negotiations in each particular case. Furthermore, caps and discounts and “most favoured nation” clauses are typically agreed upon.
On the other hand, a SAFE is a cash deposit combined with the option to subscribe for shares in the target company. Unlike convertible loans, SAFEs are usually structured as interest-free investments with no fixed maturity date. While convertible loan agreements typically exclude ordinary termination rights (except for termination for good cause), SAFEs generally do not provide for any termination options at all. Conversion is mandatory at the next financing round following the SAFE, with additional triggers potentially including liquidity events. The conversion economics mirror convertible loan practice, relying on valuation caps and/or discounts, though pre-money caps are more common than post-money caps in Germany. Most-favoured-nation clauses remain optional but are less universally adopted than in US practice.
-
How prevalent is the use of venture or growth debt as an alternative or supplement to equity fundraisings or other debt financing in the last 24 months?
Venture debt remains a niche segment within the German venture capital landscape, especially when compared to traditional venture capital equity financing. Over the past two years, however, the segment has shown measurable growth rather than stagnation. Whilst the collapse of Silicon Valley Bank in early 2023 initially contributed to market uncertainty, the principal drivers of venture debt activity in 2024 and 2025 have been structural: more selective equity markets, a slower exit environment, and growing demand from maturing, venture-backed companies for additional, often non-dilutive, capital. Globally, venture debt is forecast to reach a market volume of approximately USD 43 billion in 2025, and studies assess that venture debt accounts for as much as 15% of all venture capital transactions in the US – figures that underscore the significant growth potential for this financing instrument in Germany.
This growth has been driven by increasing demand for alternative financing solutions across Europe. As more start-ups backed by institutional venture capital mature and enter later-stage growth phases, their need for additional capital – particularly capital that does not dilute existing shareholders – has risen significantly. In the current environment, marked by higher interest rates, macroeconomic volatility, and comparatively more difficult access to lucrative exits, venture debt has become an increasingly attractive complementary funding option, particularly in the run-up to exits or milestones. Recent data indicates a clear upward trajectory in deal activity, reinforcing the view that venture debt is gaining a stronger foothold in the German financing landscape.
The continued development of venture debt offerings, supported by evolving market infrastructure and regulatory frameworks, appears to be an important prerequisite for this still relatively young segment to make an increasing contribution to improving the German venture capital financing environment over the medium term.
-
What are the customary terms of venture or growth debt in the jurisdiction and are there standard form documents?
In Germany, venture debt financing is primarily documented through a comprehensive loan agreement, which forms the core of the contractual framework. Depending on the structure of the deal, this may be supplemented by a separate equity-kicker agreement (such as a warrant instrument) and various security documents, including account pledges, global assignment agreements over receivables, and – where applicable – share pledges (which, in the case of GmbH shares, require notarisation under German law). Increasingly, these agreements follow the structural architecture of Loan Market Association (LMA) facility templates, though they are typically adapted to reflect venture-specific credit risk and often heavily negotiated, particularly with respect to equity participation rights. There is no single “market standard” venture debt form in Germany; documentation remains largely precedent- and lender-template-driven.
The contractual mechanics largely mirror those of conventional corporate lending. Disbursement is subject to conditions precedent, in particular, that agreed securities are provided and certain representations remain accurate. The creditworthiness of the company is confirmed by representations and warranties as of the relevant signing or drawdown date and is monitored through a package of covenants during the loan’s term. These covenants are often calibrated to venture-stage companies – focusing on liquidity, runway, and compliance with equity investor arrangements – rather than traditional leverage or cashflow tests. A breach of covenant, the inaccuracy of a representation or warranty, or any payment default typically constitutes an event of default and may entitle the lender to acceleration and enforcement rights.
In order to monitor the company’s financial situation and ensure compliance with the covenants, the lender usually receives regular financial and operational reporting and may, depending on the agreement, be entitled to appoint an observer to the company’s advisory board (Beirat), where one exists or is established for that purpose.
-
What are the current market trends for venture capital in the jurisdiction (including the exits of venture backed companies) and do you see this changing in the next year?
A key trend in the German venture capital market remains the focus on technology-driven start-ups. Germany continues to benefit from a strong innovation base, and investors remain particularly attracted to scalable software and deep-tech themes. At the same time, Germany’s policy framework continues to be geared towards strengthening the start-up ecosystem (e.g., Future Fund, public co-investment initiatives and reforms improving the ESOP/tax environment), which supports Germany’s attractiveness for both domestic and international investors.
After a significant decline in investment activity in 2023, the German venture capital market has shown clear signs of recovery over the past two years. In 2024, approximately EUR 7.5 billion (i.e. USD 8.5 billion) was deployed in Germany, placing it third in Europe behind the UK (USD 19.4 billion) and France (USD 8.8 billion), out of a total European venture capital investment volume of USD 63.8 billion. In 2025, investment activity in Germany broadly stabilised, with approximately EUR 7.2 billion deployed, reflecting a sideways movement at a comparatively elevated level. However, this recovery has taken a particular shape: whilst overall financing volumes have increased, the number of deals has continued to decline. In other words, more capital is being deployed, but it is increasingly concentrated in fewer, larger rounds. This “more capital, fewer deals” pattern reflects a market that has become more selective and is focusing on perceived category leaders and later-stage opportunities, often with strong participation by international investors. The previous downturn now appears to have been a market correction, giving way to a more concentrated yet cautiously optimistic environment. At the same time, Germany has continued to produce new unicorns, and activity in the venture capital secondary market has grown, driven by narrowing pricing gaps and strong investor interest in generative AI and AI-native companies.
How the recent introduction of substantial and across-the-board tariffs by the US administration might impact German start-up companies – that have benefitted from access to the US both as a source of capital and as a significant market for their goods and services – remains to be seen. While this development may lead some European founders to start their businesses in the US, the option to “flip” existing, more mature companies to the US comes with substantial complexity, ranging from corporate law and taxation to immigration issues. The more likely response by German start-ups may therefore be to focus on the domestic European markets and to seek to expand sales into other world regions. Companies offering services, rather than producing or delivering goods, are less affected by tariffs, which applies to a significant number of companies within the German start-up community.
Regarding valuations, late-stage pricing has come under more pressure than early-stage valuations since the 2022/2023 correction, with investors now prioritising fundamentals and a path to profitability over growth at any cost. At the European level, the share of financing rounds with flat or reduced pre-money valuations has continued to decline, as the post-2021 correction process appears to have largely run its course. Exit valuations have likewise shown signs of recovery compared to the prior year, with median exit sizes reaching elevated levels, driven in particular by increased investor appetite for buyout transactions.
In recent years, targets and founders often set the pace for financing rounds. Today, venture investors have reasserted control over transaction processes and documentation. Investor-friendly provisions—including enhanced liquidation preferences, anti-dilution protection, drag-along rights and protective provisions—are becoming more common and shifting more clearly in favour of investors. Notably, investors have more frequently been able to negotiate participating liquidation preferences across all stages of a company’s development cycle compared with recent years, although a non-participating 1x liquidation preference with a conversion right for the investor continues to constitute the default. There has not been widespread adoption of increasing preference multiples to more than 1x outside of distress scenarios.
Exit activity remains challenging: IPO activity has stayed subdued, with several high-profile plans postponed. Across Europe, there were 100 IPOs in 2025, which remains a ten-year low and reflects the ongoing difficulties in the European exit environment. On average, from the time of first funding to IPO, it took venture capital-backed companies that went public in 2025 almost 2 years longer than in 2023 – a median of 9.4 years globally. M&A continues to dominate as the primary exit route, whilst secondaries have become an increasingly important liquidity tool. There are early signs of gradual improvement, but a broad IPO reopening in Germany is not expected in the near term.
Investment momentum has shifted sectorally: AI-native and software-heavy businesses, deep tech, energy/cleantech and healthcare now attract the strongest activity, with software and analytics (including AI) leading by volume. According to recent data, AI-related start-ups accounted for approximately 41% of Germany’s total venture capital volume in 2025, underscoring the sector’s dominant position. Defence and security-adjacent technologies are also attracting growing interest, as illustrated by significant funding rounds such as those of German start-ups Helsing, Quantum Systems, Tytan Technologies, and the establishment of the NATO Innovation Fund (NIF) – backed by 24 allied nations and equipped with EUR 1 billion. This trend is expected to be further fuelled by the recent constitutional amendment in Germany partially lifting debt limitations for defence-related spending. Regionally, Bavaria (particularly Munich) has become increasingly competitive with Berlin by investment volume – driven by large AI and deep-tech rounds – though Berlin remains highly significant by deal count.
Over the next twelve months, the most likely scenario is a continuation of the current pattern: selective deployment concentrated in AI and deep tech, and incremental exit improvement primarily via M&A and secondaries. The expansion of the private secondary market – which grew globally from USD 109 billion to a record high of USD 152 billion – is expected to continue providing an increasingly important liquidity mechanism for venture capital-backed companies and their shareholders. Additionally, evergreen fund structures with indefinite investment horizons, while still a rare exception in the German market, may gain further traction as the industry seeks to mitigate the cyclicality of private markets. Key uncertainties remain geopolitical risks and trade-policy developments. On the positive side, Germany is working to mobilise additional private capital and strengthen structural conditions for start-ups, which may gradually support both financing and exit conditions.
-
Are any developments anticipated in the next 12 months, including any proposed legislative reforms that are relevant for venture capital investor in the jurisdiction?
Over the next 12 months, anticipated developments for venture capital investors in Germany are likely to be driven more by implementation of investment and capital-mobilisation initiatives than by new start-up-specific legislation.
On the policy side, the German government is rolling out the Germany Fund (Deutschlandfonds) to mobilise private investment via public funds and guarantees. This is expected to be particularly relevant for growth financing, public-private co-investment and the financing environment for scale-ups and strategically important tech sectors.
On the regulatory side, the EU AI Act remains a key topic for AI-heavy portfolios: whilst some obligations already apply, the next major step is the application of requirements for high-risk AI systems and transparency rules from August 2026. This will increase compliance, diligence and documentation demands for AI start-ups and is likely to become a more standardised part of investment processes. In addition, German regulators may need to provide interpretive guidance on how other emerging EU legislation – including the Data Act and the Cyber Resilience Act – applies to start-up business models and investor operations, adding further layers of regulatory complexity for venture capital-backed companies.
For exits, EU-level capital markets reforms (the EU Listing Act) are intended to reduce friction and costs around listings, though this will not by itself reopen IPO markets in the near term.
Furthermore, the European Commission’s so-called “Omnibus” package, which proposes, inter alia, far-reaching simplifications regarding key ESG regulations – notably the Corporate Sustainability Reporting Directive (CSRD) and the Corporate Sustainability Due Diligence Directive (CS3D) – aims to reduce the regulatory burden on businesses and thus enhance the EU’s global competitiveness. If adopted in its current form, this initiative is expected to have a positive impact on the venture capital ecosystem by materially reducing compliance costs for portfolio companies and improving the overall investment environment.
Germany: Venture Capital
This country-specific Q&A provides an overview of Venture Capital laws and regulations applicable in Germany.
-
Are there specific legal requirements or preferences regarding the choice of entity and/or equity structure for early-stage businesses that are seeking venture capital funding in the jurisdiction?
-
What are the principal legal documents for a venture capital equity investment in the jurisdiction and are any of them publicly filed or otherwise available to the public?
-
Is there a venture capital industry body in the jurisdiction and, if so, does it provide template investment documents? If so, how common is it to deviate from such templates and does this evolve as companies move from seed to larger rounds?
-
Are there any general merger control, anti-trust/competition and/or foreign direct investment regimes applicable to venture capital investments in the jurisdiction?
-
What is the process, and internal approvals needed, for a company issuing shares to investors in the jurisdiction and are there any related taxes or notary (or other fees) payable?
-
How prevalent is participation from investors that are not venture capital funds, including angel investors, family offices, high net worth individuals, and corporate venture capital?
-
What is the typical investment period for a venture capital fund in the jurisdiction?
-
What are the key investment terms which a venture investor looks for in the jurisdiction including representations and warranties, class of share, board representation (and observers), voting and other control rights, redemption rights, anti-dilution protection and information rights?
-
What are the key features of the liability regime (e.g. monetary damages vs. compensatory capital increase) that apply to venture capital investments in the jurisdiction?
-
How common are arrangement/ monitoring fees for investors in the jurisdiction?
-
Are founders and senior management typically subject to restrictive covenants following ceasing to be an employee and/or shareholder and, if so, what is their general scope and duration?
-
How are employees typically incentivised in venture capital backed companies (e.g. share options or other equity-based incentives)?
-
What are the most commonly used vesting/good and bad leaver provisions that apply to founders/ senior management in venture capital backed companies?
-
What have been the main areas of negotiation between investors, founders, and the company in the investment documentation, over the last 24 months?
-
How prevalent is the use of convertible debt (e.g. convertible loan notes) and advance subscription agreement/ SAFEs in the jurisdiction?
-
What are the customary terms of convertible debt (e.g. convertible loan notes) and advance subscription agreement/ SAFEs in the jurisdiction and are there standard from documents?
-
How prevalent is the use of venture or growth debt as an alternative or supplement to equity fundraisings or other debt financing in the last 24 months?
-
What are the customary terms of venture or growth debt in the jurisdiction and are there standard form documents?
-
What are the current market trends for venture capital in the jurisdiction (including the exits of venture backed companies) and do you see this changing in the next year?
-
Are any developments anticipated in the next 12 months, including any proposed legislative reforms that are relevant for venture capital investor in the jurisdiction?